We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ROQ market cap is 5.88M. The company's latest EPS is GBP -0.0125 and P/E is -3.64.
Year End 31 December 2022 | 2021 | 2022 |
---|---|---|
GBP (£) | GBP (£) | |
Total Revenue | 1,000 | 0 |
Operating Income | -916k | -1.63M |
Net Income | -916k | -1.62M |
Year End 31 December 2022 | 2021 | 2022 |
---|---|---|
GBP (£) | GBP (£) | |
Total Assets | 4.56M | 7.77M |
Total Liabilities | 477k | 561k |
Total Equity | 4.08M | 7.21M |
Year End 31 December 2022 | 2021 | 2022 |
---|---|---|
GBP (£) | GBP (£) | |
Operating | -516k | -1.58M |
Investing | -606k | -103k |
Financing | 2.02M | 3.1M |
Market Cap | 5.88M |
Price to Earnings Ratio | -3.64 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.53 |
Price to Book Ratio | 0.82 |
Dividend Yield | - |
Shares Outstanding | 129.15M |
Average Volume (1 week) | 330.73k |
Average Volume (1 Month) | 864.01k |
52 Week Change | -32.59% |
52 Week High | 9.25 |
52 Week Low | 4.00 |
Spread (Intraday) | 0.1 (2.17%) |
Company Name | Roquefort Therapeutics Plc |
Address |
eccleston yards london SW1W 9NF |
Website | https://www.roquefortplc.com |
Industry | cmp integrated sys design (7373) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions